# Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer

> **NCT00002823** · PHASE3 · COMPLETED · sponsor: **Gustave Roussy, Cancer Campus, Grand Paris** · enrollment: 3300 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** etoposide
- **DRUG:** vinblastine sulfate
- **DRUG:** vindesine
- **DRUG:** vinorelbine tartrate
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00002823
- **Lead sponsor:** Gustave Roussy, Cancer Campus, Grand Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-02
- **Primary completion:** 2001-01
- **Final completion:** —
- **Target enrollment:** 3300 (ESTIMATED)
- **Last updated:** 2013-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002823, "Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00002823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*